VOXDALE
ActiveSummary
VOXDALE has been active since 1988 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €12.4m and a net result of -€41,756. Equity remains stable across the filed financial years (±0.2% per year). Its solvency ranks better than 95% of 230 sector peers (NACE 22, financial year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).
Group and network
Holdings and subsidiaries
6 holdings · 8 subsidiaries in the treeHoldings 6
Source for every holding own accounts 2025
- MedicemsubsidiaryEquity €967,760Result €71,29099.6%
- KELA VETERINARIAsubsidiaryEquity €5.5mResult €10,43399.23%
-
96%
- Equity €31.9mResult -€1.2m93.09%
- Equity €934,134Result €691,5232%
- KELA DE LAS AMERICASMXEquity MXN 3.4mResult MXN 639,7851%
All subsidiaries, including indirect ones 8
Companies in which this company or one of its subsidiaries holds more than half, or which it consolidates according to the LEI register.
- Medicem 99.6%
- KELA VETERINARIA 99.23%
- BIAGRAL 96%
KELA - Kempisch Laboratorium - Kela Laboratoria 93.09%4 subsidiaries
- ANUPCO LTDGB 100%
- KELA DE LAS AMERICASMX 100%
- KELA HONG KONG LTDHK 100%
- PHENIX PROPERTY 98%
According to the 2025 annual accounts of VOXDALE and those of the other companies, the acts in the Belgian Official Gazette and the LEI register. Annual accounts state the shareholders that notified the company under article 7:225 of the Code of Companies and Associations and the parent companies that consolidate it. The register of ultimate beneficial owners (UBO) is not public: who ultimately stands behind a natural person or a foreign parent is not stated here. A company that does not include these statements in its annual accounts, or does not have to, is not listed.
Connections & network
1 current directorThe board mandates are listed below; here you explore them as a network.